RealFeedApp New study divides MASLD into five subtypes
Researchers from Mayo Clinic have reclassified metabolic dysfunction-associated steatotic liver disease into five distinct categories. This approach enables more precise assessment of treatment options and risks for fibrosis, cirrhosis, and cardiovascular disease.
- Field
- medicine and diagnostics
- What they did
- Researchers from Mayo Clinic demonstrated that metabolic dysfunction-associated steatotic liver disease (MASLD) consists of five distinct types rather than a single disease.
- Why it matters
- This classification will enable doctors to better assess individual patient risks and select more effective treatments, as different types of the disease lead to varying outcomes like cirrhosis or cardiovascular issues.
#masld#liver disease#fibrosis#cirrhosis#mayo clinic
